|
SLC37A3 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.89770000000356E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.479100E-03 |
| Normal-vs-Stage2 |
1.831820E-04 |
| Normal-vs-Stage3 |
1.369630E-04 |
| Normal-vs-Stage4 |
1.281120E-03 |
| Stage1-vs-Stage2 |
1.576780E-01 |
| Stage1-vs-Stage3 |
9.248000E-02 |
| Stage1-vs-Stage4 |
2.532600E-01 |
| Stage2-vs-Stage3 |
8.881800E-01 |
| Stage2-vs-Stage4 |
8.238000E-01 |
| Stage3-vs-Stage4 |
9.116400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.43939999999832E-05 |
| Normal-vs-AfricanAmerican |
7.020100E-03 |
| Normal-vs-Asian |
2.832000E-01 |
| Caucasian-vs-AfricanAmerican |
9.675600E-01 |
| Caucasian-vs-Asian |
2.155700E-02 |
| AfricanAmerican-vs-Asian |
1.052370E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.540100E-03 |
| Normal-vs-Female |
2.796800E-04 |
| Male-vs-Female |
3.485600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.596900E-03 |
| Normal-vs-Age(41-60Yrs) |
5.81809999999905E-05 |
| Normal-vs-Age(61-80Yrs) |
2.187200E-04 |
| Normal-vs-Age(81-100Yrs) |
9.905800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.152410E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.391630E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.818400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.853600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.156000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.752600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.056100E-02 |
| Classical-VS-Follicular |
9.821600E-01 |
| Classical-VS-Other |
5.011600E-01 |
| Classical-VS-Normal |
1.697660E-03 |
| Tall-VS-Follicular |
6.491700E-02 |
| Tall-VS-Other |
2.577400E-01 |
| Tall-VS-Normal |
8.14930000000436E-05 |
| Follicular-VS-Other |
3.299000E-01 |
| Follicular-VS-Normal |
1.238280E-02 |
| Other-VS-Normal |
9.976200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.8428999999991E-05 |
| Normal-vs-N1 |
6.503800E-03 |
| N0-vs-N1 |
9.128000E-01 |
|
|
